Brendan P. Glackin

Brendan P. Glackin

Attorney Profile

Top Rated Antitrust Litigation Attorney in San Francisco, CA

Lieff Cabraser Heimann & Bernstein, LLP
 | 275 Battery Street, 29th Floor
San Francisco, CA 94111
Phone: 415-956-1000
Fax: 415-956-1008
Selected To Super Lawyers: 2013 - 2021
Licensed Since: 1998
Education: Harvard Law School
Practice Areas:
  • Antitrust Litigation (50%),
  • Securities Litigation (50%)
    Attorney Profile

    Brendan P. Glackin possesses a wealth of antitrust litigation and trial experience from more than 20 years of practice and more than 20 civil and criminal jury trials. His successes include the titanium dioxide antitrust class action ($163.5 million in settlements); the liquid crystal displays (LCDs) price-fixing litigation ($470 million in settlements); and the Norvir antitrust litigation. Glackin served as trial counsel in all three cases and, via LCDs, remains one of small number of plaintiff attorneys in America to have successfully taken a class action antitrust case to verdict before a jury. His work against price-fixing cartels has continued in his representation of a class of indirect purchasers in the Lithium Ion Batteries price-fixing litigation ($113.45 million in settlements).

    Glackin has contributed groundbreaking work in litigation against drug makers for blocking access to affordable generics. This includes the blockbuster brand-name prescription drug Cipro ($399 million in settlements), which led to a 2016 “California Lawyer Attorney of the Year” (CLAY) award. Glackin continued his work in the field of generic drugs as lead counsel for Nashville General Hospital (the Hospital Authority of Metropolitan Government of Nashville) in a class-action antitrust case against defendants for monopolizing enoxaparin, the generic version of the blockbuster life-saving anti-coagulant Lovenox. In 2019, the parties settled for $120 million, the second largest indirect-purchaser antitrust pharmaceutical settlement fund in history, after Cipro. Notably, the complaint alleged that defendants colluded to secretly bring the official batch-release testing standard for generics within the ambit of their patent, delaying the competitor—a never-before-tried theory of liability. Nashville General v. Momenta Pharmaceuticals, et al., No. 3:15-cv-01100 (M.D. Tenn.).

    Glackin also shared with others at the firm a well-deserved 2019 “Outstanding Antitrust Litigation Achievement in Private Law Practice” award from the American Antitrust Institute for his work on Seaman v. Duke, a class action case around wage suppression, challenging a secret no-hire agreement between the Duke and UNC Medical School Deans which led to a final settlement of $54.5 million in 2019. Cipro Cases I and II, JCCP Nos. 4154 and 4220 (Cal. Supr. Ct.); Seaman v. Duke University, No. 1:15-cv-00462 (M.D. N.C.).

    Glackin presently serves as lead counsel in a proposed class action against the one of the largest healthcare systems in America, Atrium Health, the dominant healthcare provider in North Carolina. The case follows on a civil enforcement action brought by the Department of Justice and the North Carolina Attorney General, which alleged harm to competition caused by anti-competitive terms in Atrium Health’s contracts with insurers. Glackin and Lieff Cabraser remain the only attorneys willing to represent hundreds of thousands of North Carolinians victimized by this conduct.

    In 2019 and 2020, Glackin was named one of Lawdragon’s 500 Leading Lawyers in America and The Daily Journal named Glackin a Top Antitrust Lawyer in California in 2020. Glackin has also been listed as a “Super Lawyer for Northern California” from 2013 to 2020.

    Glackin’s many contributions to the bar and the practice of law include the following. He has regularly been tapped to teach trial advocacy and negotiation skills by the Practising Law Institute (PLI); he is also annually invited to teach trial advocacy with the National Institute for Trial Advocacy (NITA). He serves as a Vice-Chair of the American Bar Association Section of Antitrust Law, Global Private Litigation Committee, and was a founding member of the Executive Committee of the Antitrust Section of the Bar Association of San Francisco. He has been a past panelist at the ABA Antitrust Section Spring Meeting, the pre-eminent gathering of antitrust lawyers in the world. He routinely speaks, publishes, and teaches on antitrust issues.

    About Brendan Glackin

    Admitted: 1998, California

    Professional Webpage:


    • Selected for inclusion by peers in The Best Lawyers in America in field of "Litigation - Antitrust," 2021; “Outstanding Private Practice Antitrust Achievement,” American Antitrust Institute, 2020; "Super Lawyer for Northern California," Super Lawyers, 2013-2020; "Lawdragon 500 Leading Plaintiff Financial Lawyers in America," Lawdragon, 2019-2020; "Top Antitrust Lawyers in California,” Daily Journal, 2020; “Outstanding Private Practice Antitrust Achievement,” American Antitrust Institute, 2019; "California Lawyer Attorney of the Year (CLAY) Award," California Lawyer, 2016

    Bar/Professional Activity:

    • Bar Association of San Francisco Antitrust Section, Executive Committee; State Bar of California.

    Scholarly Lectures/Writings:

    • "The Antitrust of Dominant Hospital Systems: United States v. CMHA and UFCW v. Sutter Health," ABA Antitrust Law Section, with Adam Gitlin, 2020; Antitrust and Silicon Valley: New Themes and Direction in Competition Law and Policy, Santa Clara University School of Law, 2019; Antitrust Trials: The View From the Trenches, 2013; Applying Settlements Offsets to Antiftust Judgments, ABA Spring Meetings, 2013; California Trial Advocacy, PLI, 2013; Building Trial Skills, NITA, 2013; Antitrust Institute: Developments & Hot Topics, 2011; Ramifications of American Needle, Inc. v. National Football League
    • Brendan also contributes to Google+ and the Lieff Cabraser civil justice blog.
    Show More
    Office Location for Brendan P. Glackin

    275 Battery Street
    29th Floor
    San Francisco, CA 94111

    Brendan P. Glackin:

    Last Updated: 10/21/2020

    Page Generated: 0.62229490280151 sec